Placebo to match ALKS 2680, Placebo to match Alks 2680/Alixorexton, ALKS 2680, ALKS 2680 clinical trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

This study is testing a new medicine, ALKS 2680, for adults with Narcolepsy Type 1. Researchers want to see if it helps reduce sleepiness and is safe. Some people will get the new medicine, and others will get a dummy medicine (placebo).